In the MCC model, both CD4+ T cells (33.7 ± 12.2%) and CD8+ T cells (54.1 ± 16.4%) populations were identified in the iPDX peripheral blood (Fig 1C). This evidence concerns the gene CD8A and Merkel cell skin cancer.